Robert T Foster Insider Trading $HEPA Hepion Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert T Foster.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert T Foster. Robert T Foster is CEO and CSO in Hepion Pharmaceuticals, Inc. ($CTRV) and CEO and Director in Hepion Pharmaceuticals, Inc. ($CTRV) and CEO,CSO and Director in Hepion Pharmaceuticals, Inc. ($CTRV) and Chief Scientific Officer in ContraVir Pharmaceuticals, Inc. ($CTRV).
Robert T Foster in Hepion Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert T Foster: CEO and Director, CEO,CSO and Director, CEO and CSO, Chief Scientific Officer
Holdings: 45,259 shares
Current Value: $63,363
Latest Transaction: Feb 18 2021
$HEPA Market Capitalization: $85.72M
$HEPA Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Robert T Foster in Hepion Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2021 | CTRV | Hepion Pharmaceuti ... | Foster Robert T | CEO and Director | Buy | P | 2.00 | 20,000 | 40,000 | 45,259 | 25.3 K to 45.3 K (+79.18 %) |
| Dec 08 2020 | CTRV | Hepion Pharmaceuti ... | Foster Robert T | CEO and Director | Buy | P | 1.58 | 25,000 | 39,418 | 25,259 | 259 to 25.3 K (+9,652.51 %) |
| Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | Foster Robert T | CEO,CSO and Directo ... | Option Exercise | A | 3.72 | 212,000 | 788,640 | 601,879 | |
| Apr 07 2020 | CTRV | Hepion Pharmaceuti ... | Foster Robert T | CEO and CSO | Option Exercise | A | 1.63 | 380,000 | 619,400 | 389,879 | |
| Jul 25 2019 | CTRV | Hepion Pharmaceuti ... | Foster Robert T | CEO and CSO | Option Exercise | A | 3.24 | 9,700 | 31,428 | 9,879 | |
| Jan 05 2018 | CTRV | ContraVir Pharmace ... | Foster Robert T | Chief Scientific Of ... | Grant | A | 0.00 | 100,654 | 0 | 144,736 | 44.1 K to 144.7 K (+228.33 %) |
| Jul 07 2017 | CTRV | ContraVir Pharmace ... | Foster Robert T | Chief Scientific Of ... | Grant | A | 0.00 | 44,082 | 0 | 44,082 | 0 to 44.1 K |
Page: 1